PR Newswire
September 25, 2007
FAIRFAX, Va. -- The American Society for Therapeutic Radiology and Oncology has published an updated version of its brochure Radiation Therapy for Gynecologic Cancers. The brochure provides women coping with a gynecologic cancer useful information on the different types of radiation therapy and their treatment options, as well as new information on the potential side effects and how to care for themselves while undergoing treatment.
"Being diagnosed with a gynecologic cancer can be an overwhelming experience and making sense of the different treatments available is not an easy task," said Thomas Eichler, M.D., Chair of ASTRO's Communications Committee and a radiation oncologist at the Thomas Johns Cancer Center in Richmond, Va. "We hope this updated brochure will help patients better understand the different types of treatments available and allow them to make the best, most informed decision about which treatment to receive."
According to the American Cancer Society, nearly 80,000 women per year are diagnosed with some type of gynecologic cancer. Uterine, cervical and ovarian cancers are the most common types and account for more than 72,000 of these new diagnoses each year. Patients will be able to use the new brochure when discussing with their healthcare provider the possibility of using radiation therapy as part of their treatment.
This four-color brochure is a part of ASTRO's award-winning public awareness campaign that includes 17 brochures available in English and Spanish. Brochures can be downloaded for free at http://www.RTanswers.org and hard copies can be purchased at http://www.astro.org/shop/ for $30 for 50 copies for nonmembers and $25 for 50 copies for members.
ASTRO is the largest radiation oncology society in the world, with 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.
Copyright (C) 2007 PR Newswire. All Rights Reserved
